Day: April 27, 2021

AIM ImmunoTech Announces Positive Safety Data in Second Cohort of Phase 1 Clinical Study Investigating Intranasal Administration of Ampligen as a Potential Prophylaxis or Treatment for COVID-19 and Other Respiratory Viral Diseases

Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use

Development of Krysalis(TM) Therapeutic Pod to Deliver Headset-free Virtual Experience with Biometric MonitoringVancouver, British Columbia--(Newsfile Corp. - April 27, 2021)...

Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead

DEFINING CLEAR DEVELOPMENT PATHWAY FOR NEXT GENERATION OF PSYCHEDELIC MEDICINES TO TREAT ADDICTIONToronto, Ontario--(Newsfile Corp. - April 27, 2021) -...

error: Content is protected !!